anti-ovarian cancer therapeutics (Ohio State University/Ohio State University Technology Commercialization and Knowledge Transfer)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Nameanti-ovarian cancer therapeutics (Ohio State University/Ohio State University Technology Commercialization and Knowledge Transfer)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe Ohio State University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe Ohio State University
Active IndicationsN/A
Inactive IndicationsOvarian Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A